Johnson and Johnson Vision showcased their new Veritas Vision System and a range of clinical data relating to their products at the ESCRS. Veritas Vision System is a phaco system designed to address three critical areas: patient system, surgeon efficiency and comfort. Johnson and Johnson Vision have also presented several other products at ESCRS, including Tecnis Synergy IOL, Tecnis Eyhance IOL and Tecnis Toric II IOL. “The Veritas Vision System is designed to give better fluidics and increased chamber stability, and has had excellent feedback from the clinical community.” Warren Foust, Worldwide President, Surgical at Johnson & Johnson Vision.
Plasmapp has showcased the world’s fastest sterilizer, STERLINK – a novel plasma sterilizer for medical devices using STERPACK technology which enables the fastest sterilization cycle time at low temperatures. STERLINK’s safety and reliability as medical equipment is proven by FDA approval in 14 countries. It is also free from toxic EO gas, making it eco-friendly and harmless.
VSY Biotechnologies launched its first trifocal IOL at the ESCRS Symposium. With the tri-focal lens, VSY Biotechnologies are introducing their concept of Golden Ratio in IOL Technology™ with AcrivaUD Trinova Pro C Pupil Adaptive™ for cataract and Refractive Lens Exchange patients to provide the highest level of visual quality in various lighting.
Lumenis presents its first FDA-approved IPL OptiLight to treat dry eye disease due to meibomian gland dysfunction and provide a precise and comfortable dry eye procedure for patients. OptiLight elevates dry eye management with Lumenis’ patented Optimal Pulse Technology™ and user-centred design.
Ref: https://eyewire.news/news/johnson-johnson-vision-showcases-new-veritas-vision-system-and-presents-latest-clinical-data-at-escrs-2021 https://ophthalmologybreakingnews.com/plasmapp-showcases-the-worlds-fastest-sterilizer-sterlinktm-at-escrs-2021- https://ophthalmologybreakingnews.com/vsy-biotechnology-readies-for-the-launch-of-first-trifocal-iol-at-escrs-satellite-symposium- https://ophthalmologybreakingnews.com/escrs--lumenis-presents-the-first-and-only-fda-approved-ipl-optilight-to-treat-dry-eye-disease-
James Pickering is our Managing Director and an eye care recruitment expert who has developed an extensive client base and candidate network. He regularly writes articles about industry developments and has received numerous recommendations from industry leaders. You can also connect with James on LinkedIn to stay up to date on the latest eye care news.